These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24275268)

  • 1. Trichomoniasis: the "neglected" sexually transmitted disease.
    Meites E
    Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomoniasis.
    Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
    Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.
    Getaneh FW; Oliveira CR; Pathy S; Sheth SS
    Am J Obstet Gynecol; 2023 Sep; 229(3):284.e1-284.e10. PubMed ID: 37393012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic options for the treatment of human trichomoniasis.
    Küng E; Fürnkranz U; Walochnik J
    Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community.
    Munson E; Napierala M; Schell RF
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):845-63. PubMed ID: 23944153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. United Kingdom National Guideline on the Management of Trichomonas vaginalis 2014.
    Sherrard J; Ison C; Moody J; Wainwright E; Wilson J; Sullivan A
    Int J STD AIDS; 2014 Jul; 25(8):541-9. PubMed ID: 24616117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichomoniasis in teens: an update.
    Huppert JS
    Curr Opin Obstet Gynecol; 2009 Oct; 21(5):371-8. PubMed ID: 19491679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-Resistant Trichomoniasis: Successful Treatment With 3 Months of Twice-Daily Intravaginal Boric Acid.
    Seyedroudbari S; McCloskey K; Muzny CA; Graziani A; Momplaisir F
    Sex Transm Dis; 2023 Jul; 50(7):452-454. PubMed ID: 36940199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trichomoniasis].
    Yasuda J
    Nihon Rinsho; 2009 Jan; 67(1):162-6. PubMed ID: 19177767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious disease: New Trichs: screening and therapy.
    Killock D
    Nat Rev Urol; 2014 Aug; 11(8):427. PubMed ID: 24980196
    [No Abstract]   [Full Text] [Related]  

  • 17. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
    Van der Pol B
    Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine.
    Cudmore SL; Garber GE
    J Infect Public Health; 2010; 3(2):47-53. PubMed ID: 20701891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of
    Sherrard J; Pitt R; Hobbs KR; Maynard M; Cochrane E; Wilson J; Tipple C
    Int J STD AIDS; 2022 Jul; 33(8):740-750. PubMed ID: 35701863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea.
    Kim SR; Kim JH; Gu NY; Kim YS; Hong YC; Ryu JS
    Korean J Parasitol; 2016 Apr; 54(2):187-90. PubMed ID: 27180577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.